Objective: Thyroid blood flow is greatly enhanced in untreated Graves' disease, but it is not known whether it is due to thyroid hormone excess or to thyroid hyperstimulation by TSH-receptor antibody. To address this issue in vivo patients with different thyroid disorders were submitted to color flow doppler sonography (CFDS).
Introduction
Hyperthyroidism is associated with hemodynamic changes including high output state, increased heart rate and cardiac contractility, and decreased peripheral resistance (1, 2) , that are related both to direct cardiostimulatory effects of thyroid hormone and to increased peripheral oxygen consumption (3, 4) . While cardiac parameters are invariably increased, as assessed by the shortening of systolic and diastolic time-intervals, the increase of systolic and diastolic function and the reduction in the left ventricular ejection fraction (3) (4) (5) (6) , regional blood flow distribution is not uniform in hyperthyroidism. For example, blood flow in skeletal muscle, skin, cerebral, and coronary arteries is increased, whereas hepatic blood flow is unchanged (7) (8) (9) .
Untreated Graves' patients have a hypervascular gland responsible for a thyroid bruit and thrill. The availability of color flow doppler sonography (CFDS), a rapid, informative, and non-invasive technique, has recently allowed direct measurement of intrathyroidal blood flow (10) (11) (12) (13) (14) (15) (16) (17) . Using CFDS it has been shown that intrathyroidal blood flow, which can be quantitated by measurement of peak systolic velocity (PSV), is greatly increased in patients with untreated Graves' hyperthyroidism (10, 11) . In hyperthyroidism hemodynamic changes are thought to be due to serum thyroid hormone excess. However, in Graves' patients it is not well understood whether thyroidal hypervascularity is related to thyroid hormone excess or to the excessive stimulation of the thyroid gland by TSH-receptor antibody (TRAb). To address this problem, in the present study we have evaluated the intrathyroidal blood flow and PSV by CFDS in patients with various thyroid disorders.
Materials and subjects
We enrolled in this study 155 consecutive patients seen at our Institution in the period 1995-1997. The main clinical and biochemical features of the subjects are described in Table 1 .
Conventional and CFD sonography
CFDS was performed using an ALU-4 ESAOTE color doppler system (Esaote Biomedicals, Genua, Italy) with a 7. Normal subjects were recruited among medical personnel of our Institution. Patients with toxic adenoma had a single hot thyroid nodule at scintiscan with absent radioiodine uptake in the extranodular tissue. Patients with thyrotoxicosis factitia had low/suppressed thyroidal 24-h radioiodine uptake values (3 Ϯ 1%), normal urinary iodine excretion, and undetectable serum Tg (18) . All patients admitted surreptitious thyroid hormone pill intake. Five patients were previously described in detail (16 
Results
The results are summarized in Table 2 and in Fig. 1 . Patients with hyperthyroidism had higher PSV values than controls (P Յ 0.004), patients with thyrotoxicosis (P Յ 0.004), and hypothyroid and euthyroid patients with goitrous Hashimoto's thyroiditis (P Յ 0.0005).
Patients with thyrotoxicosis had PSV values which did not differ from those observed in controls and euthyroid patients with goitrous Hashimoto's thyroiditis.
Hypothyroid patients with goitrous Hashimoto's thyroiditis had higher PSV values than euthyroid patients with goitrous Hashimoto's thyroiditis (P = 0.0004), controls (P = 0.026) and patients with thyrotoxicosis ((P Յ 0.01).
Discussion
The results of the present study confirmed that CFDS is a useful tool to investigate intrathyroidal blood flow and clearly demonstrated that thyroid vascularity and blood flow are mainly dependent on the activation of TSH receptor by TSH, TRAb, or by gain of function mutations of TSH receptor (19) , while thyrotoxicosis per se does not cause hemodynamic changes in intrathyroidal vessels. Increased PSV values were observed only in conditions associated with elevated TSH values (mainly central hyperthyroidism due to TSHoma and, to a lesser extent, untreated hypothyroidism due to goitrous Hashimoto's thyroiditis), with the presence of the abnormal TSHreceptor stimulator (TRAb, in untreated Graves' hyperthyroidism) or with gain of function mutations of TSH receptor (toxic adenoma), irrespective of serum thyroid hormone levels (elevated in TSHoma, toxic adenoma and Graves' disease, low in Hashimoto's hypothyroid patients). The fact that the increase in PSV values was modest in hypothyroid patients, and marked in the other two groups, in spite of very high TSH values in the former group, is in keeping with the concept that a responsive (and not damaged) thyroid gland is also required to achieve a substantial increase in thyroid vascularity and blood flow. Autoimmunity per se is unlikely to be the cause of thyroid hypervascularity. In fact, autoimmunity is present in patients with Graves' disease and in patients with Hashimoto's thyroiditis, but hypervascularity is observed only in the presence of TRAb or of increased serum TSH values. Thyroid volume might play some role. However, patients with increased serum TSH levels (TSHoma and hypothyroid patients) had similar thyroid volume (Table 2) but PSV values significantly differed in the two groups (Fig. 1) . The importance of thyroid stimulators is supported by recent reports (20, 21) showing that TSH can drive thyroidal angiogenesis in Table 2 Sonography and color doppler characteristics of the subjects. vitro: this effect might be mediated by the increased expression of growth factors of the vasculotropins and the tyrosine kinase receptor families, which are then released by thyroid follicular cells and in turn act on endothelial cells. It is conceivable that similar effects might be exerted by TRAb. On the other hand, the ineffectiveness of elevated serum thyroid hormones to increase intrathyroidal blood flow might be explained by the recent findings of Diekman et al. (22) , who reported that human endothelial cells contain thyroid hormone receptor, but do not produce endothelin in response to thyroid hormone stimulation. Endothelin is a 21 amino acid peptide which is both a vasoconstrictor and a smooth-muscle mitogen, and might have a role in modulating regional blood flow (23, 24) . Our data showed that some hypothyroid patients had CFDS pattern II similar to patients with Graves' disease or TSHoma. However, PSV values were only slightly elevated in hypothyroid patients, but greatly increased in the hyperthyroid patients. Thus, CFDS pattern and PSV values are not always superimposable: CFDS pattern II might be found in association, for example, either with a 6 cm/s PSV (hypothyroid patients with Hashimoto's thyroiditis) or with 15 cm/s PSV (Graves' hyperthyroidism or TSHoma). For these reasons, we would like to suggest that PSV represents a better index of thyroid function than the CFDS pattern. High PSV values are probably indicative of hyperthyroidism, since they reflect a sustained stimulation on a thyroid which is capable of producing and secreting excess thyroid hormone; this does not occur in goitrous Hashimoto's hypothyroidism, in which the sustained stimulation of TSH leads only to a moderate increase in thyroid vascularity and blood velocity, due to the damage of thyroid tissue.
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Our data support the concept that spontaneous hyperthyroidism (i.e. a stimulation of the thyroid gland) and not thyrotoxicosis (i.e. a serum increase of thyroid hormone levels) is associated with increased intrathyroidal vascularity. This might be diffuse as in Graves' disease or circumscribed as in toxic adenoma. Thyrotoxicosis due to destructive process of thyroid gland (subacute thyroiditis or type II amiodaroneinduced thyrotoxicosis (17)) or to exogenous ingestion of thyroid hormons (16) are not associated with an increased PSV or CFDS pattern.
Because it is easy, non-invasive and rapid, CFDS and, even more, PSV can provide prompt information on thyroid status. For the interpretation of CFDS pattern and PSV values the examiner must keep in mind that thyroid vascularization depends on thyroid stimulation by TSH or TRAb. Mean PSV in patients with elevated serum TSH or TRAb levels (untreated Graves' disease (TDG), TSHoma, untreated hypothyroidism due to goitrous Hashimoto's thyroiditis (HT hypo)) or with toxic adenoma (TA) was significantly higher than that found in the control group, in patients with thyrotoxicosis factitia (TF) or subacute thyroiditis (SAT) and euthyroid Hashimoto's thyroiditis (HT euthyr). For statistical differences see text. Numbers refer to the number of patients having the same individual PSV value.
